Pregled bibliografske jedinice broj: 1166013
Performance prediction algorithm for autologous PBSC collection in adults and pediatric patients using large volume leukapheresis
Performance prediction algorithm for autologous PBSC collection in adults and pediatric patients using large volume leukapheresis // Journal of clinical apheresis, 34 (2019), 4; 407-415 doi:10.1002/jca.21693 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1166013 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Performance prediction algorithm for autologous
PBSC collection in adults and pediatric
patients
using large volume leukapheresis
Autori
Bojanić, Ines ; Besson, Nelly ; Vidović, Ivana ; Golubić Ćepulić, Branka
Izvornik
Journal of clinical apheresis (0733-2459) 34
(2019), 4;
407-415
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
CD34+ cell dose ; large volume leukapheresis ; performance prediction algorithm ; peripheral blood progenitor cell collection
Sažetak
Background and Objectives: The number of CD34+ cells collected in apheresis procedures depends mainly on the collection efficiency of the device and the blood volume processed. Large volume leukapheresis (LVL) can improve CD34+ cell yield and has previously been investigated using the COBE Spectra device (Terumo BCT, USA). Materials and Methods: This was a retrospective analysis of LVL performance in patients undergoing continuous mononuclear cell collection (CMNC) using the new Spectra Optia apheresis system (Terumo BCT, USA) at the University Hospital Center, Zagreb, from March 2016 to September 2016. CD34+ cell yield predictability, determined using a customized algorithm, was also assessed. Results: In total, 67 procedures performed in 46 adults and 14 performed in 11 children were included in the analysis. In adults, 30 (65.2%) patients successfully reached their target preapheresis CD34+ cell count on day 1, with a median (interquartile range [IQR]) CD34+ collected cell dose of 4.8 × 106/kg (2.3-10.6 × 106/ kg). In the pediatric group, 81.8% successfully collected the target CD34+ cell dose on the first day, with a median (IQR) CD34+ collected cell dose of 11.1 × 106/kg (3.2-16.3 × 106/kg). The customized algorithm showed a strong and significant linear correlation with actual CD34+ cell dose (P < 0.0001). Conclusion: The results of this study support the use of LVL and the customized prediction algorithm in apheresis procedures. The ability to tailor the procedure to meet the needs of the individual patient may help to minimize the blood volume processed, shorten the duration, reduce the volume of infused anticoagulants, and improve patient comfort.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb,
Zdravstveno veleučilište, Zagreb,
Sveučilište u Splitu Sveučilišni odjel zdravstvenih studija
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE